Revenues Working Against AngioDynamics, Inc.’s (NASDAQ:ANGO) Share Price

You may think that with a price-to-sales (or “P/S”) ratio of 1.3x AngioDynamics, Inc. (NASDAQ:ANGO) is a stock worth checking out, seeing as almost half of all the Medical Equipment companies in the United States have P/S ratios greater than 2.9x and even P/S higher than 8x aren’t out of the ordinary. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s limited.

See our latest analysis for AngioDynamics

ps-multiple-vs-industry
NasdaqGS:ANGO Price to Sales Ratio vs Industry August 26th 2025

What Does…

Source link